Literature DB >> 25154327

Reply: To PMID 24687915.

Ayodeji A Asuni1, Joanna E Pankiewicz, Martin J Sadowski.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25154327      PMCID： PMC4249727          DOI： 10.1002/ana.24253

Source DB:  PubMed          Journal:  Ann Neurol        ISSN： 0364-5134            Impact factor:   10.422


× No keyword cloud information.
  8 in total

1.  A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity.

Authors:  S Weggen; J L Eriksen; P Das; S A Sagi; R Wang; C U Pietrzik; K A Findlay; T E Smith; M P Murphy; T Bulter; D E Kang; N Marquez-Sterling; T E Golde; E H Koo
Journal:  Nature       Date:  2001-11-08       Impact factor: 49.962

2.  Modulation of amyloid precursor protein expression reduces β-amyloid deposition in a mouse model.

Authors:  Ayodeji A Asuni; Maitea Guridi; Joanna E Pankiewicz; Sandrine Sanchez; Martin J Sadowski
Journal:  Ann Neurol       Date:  2014-04-28       Impact factor: 10.422

3.  Phenserine regulates translation of beta -amyloid precursor protein mRNA by a putative interleukin-1 responsive element, a target for drug development.

Authors:  K T Shaw; T Utsuki; J Rogers; Q S Yu; K Sambamurti; A Brossi; Y W Ge; D K Lahiri; N H Greig
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-12       Impact factor: 11.205

4.  Enhanced release of amyloid beta-protein from codon 670/671 "Swedish" mutant beta-amyloid precursor protein occurs in both secretory and endocytic pathways.

Authors:  R G Perez; S L Squazzo; E H Koo
Journal:  J Biol Chem       Date:  1996-04-12       Impact factor: 5.157

5.  The secreted form of the Alzheimer's amyloid precursor protein with the Kunitz domain is protease nexin-II.

Authors:  T Oltersdorf; L C Fritz; D B Schenk; I Lieberburg; K L Johnson-Wood; E C Beattie; P J Ward; R W Blacher; H F Dovey; S Sinha
Journal:  Nature       Date:  1989-09-14       Impact factor: 49.962

6.  Selective translational control of the Alzheimer amyloid precursor protein transcript by iron regulatory protein-1.

Authors:  Hyun-Hee Cho; Catherine M Cahill; Charles R Vanderburg; Clemens R Scherzer; Bin Wang; Xudong Huang; Jack T Rogers
Journal:  J Biol Chem       Date:  2010-06-17       Impact factor: 5.157

7.  The experimental Alzheimer's disease drug posiphen [(+)-phenserine] lowers amyloid-beta peptide levels in cell culture and mice.

Authors:  Debomoy K Lahiri; DeMao Chen; Bryan Maloney; Harold W Holloway; Qian-sheng Yu; Tada Utsuki; Tony Giordano; Kumar Sambamurti; Nigel H Greig
Journal:  J Pharmacol Exp Ther       Date:  2006-09-26       Impact factor: 4.030

8.  Novel 5' untranslated region directed blockers of iron-regulatory protein-1 dependent amyloid precursor protein translation: implications for down syndrome and Alzheimer's disease.

Authors:  Sanghamitra Bandyopadhyay; Catherine Cahill; Amelie Balleidier; Conan Huang; Debomoy K Lahiri; Xudong Huang; Jack T Rogers
Journal:  PLoS One       Date:  2013-07-31       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.